RxDoctor Payments Data

Dennis Vinias

Physician Assistant · Westminster, MDNPI 1912275926

Payments from drug & device makers

$5,434in general payments, 2019–2025

Across 314 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$901
  • AbbVie$705
  • Pfizer$669
  • AstraZeneca$548
  • Lilly USA, LLC$404
  • Boehringer Ingelheim$386
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$5,434100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,434 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$73,420
Medicare patients
266
Services billed
1,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide27$58,397
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$24,249
TrulicityDulaglutide15$22,433
RybelsusSemaglutide11$17,423
JardianceEmpagliflozin11$14,463
Atorvastatin Calcium219$2,760
Rosuvastatin Calcium130$2,283
Levothyroxine Sodium136$1,632
Pregabalin30$1,360
Losartan Potassium105$1,150
Bupropion XlBupropion Hcl21$779
SynthroidLevothyroxine Sodium16$772
Venlafaxine Hcl ErVenlafaxine Hcl34$742
Amlodipine Besylate103$696
Sertraline Hcl43$669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$901$75,82038 claims
GSKTrelegy Ellipta$267$24,24922 claims
Lilly USA, LLCTrulicity$404$22,43315 claims
Boehringer IngelheimJardiance$386$14,46311 claims
AbbVieSynthroid$705$77216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Westminster

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →